EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Clinical Characteristics and Mutation Profile in Patients with Carbonic Anhydrase II Deficiency: A Systematic Review of Case Reports

Rajkumar Kundavaram, Saswat Ranjan Raul, Vishnu Dev, Shruti Namdeo, Priya Gogia, Kirtisudha Mishra, Girish Chandra Bhatt

Indian Pediatrics Case Reports · 2024-10 · 4 (4) · 252-255

DOI: 10.4103/ipcares.ipcares_237_24 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background: Carbonic anhydrase II (CA II) deficiency is a rare autosomal recessive genetic disorder presenting with the characteristic triad of osteopetrosis, renal tubular acidosis (RTA), and intracerebral calcifications. However, the spectrum of mutations and clinical features varies. Objectives: A systematic review of case reports was done to describe the clinical spectrum and genetic mutations of children reported with carbonic anhydrase deficiency. Methods: A comprehensive search was done in major databases, using defined search terms. The identified reports underwent screening by different authors as per inclusion and exclusion criteria. Results: Twenty-two children (median age: 5 years) with genetically proven CA II deficiency were included, mostly males, all having RTA, classic triad being present in 64%. Over half of them had global developmental delay and one-third had vision and hearing defect, each. The most common mutation was c. 232 + 1 G >T, followed by del 12/ins4 at codon 211, seen in 9 (41%) and 4 (18%) children, respectively. Conclusion: Not all children with CA II deficiency present with triad, though RTA is present universally, c. 232 + 1 G >T being the most common variant in CA2 gene.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →